- Q2 2023 OpGen Inc Earnings Call TranscriptAug 10, 2023$3.38 (-23.42%)Earnings
- Q1 2023 OpGen Inc Earnings Call TranscriptMay 15, 2023$7 (-6.91%)Earnings
- Q4 2022 OpGen Inc Earnings Call TranscriptMar 29, 2023$13.6 (-6.85%)Earnings
- Q3 2022 OpGen Inc Earnings Call TranscriptNov 10, 2022$37 (+4.17%)Earnings
- Q2 2022 OpGen Inc Earnings Call TranscriptAug 11, 2022$126 (+5.00%)Earnings
- Q1 2022 OpGen Inc Earnings Call TranscriptMay 12, 2022$71.52 (+12.52%)Earnings
- Q4 2021 OpGen Inc Earnings Call TranscriptMar 29, 2022$170 (+10.68%)Earnings
- Q3 2021 OpGen Inc Earnings Call TranscriptNov 11, 2021$340Earnings
- Q2 2021 OpGen Inc Earnings Call TranscriptAug 12, 2021$508 (-7.30%)Earnings
- Q1 2021 OpGen Inc Earnings Call TranscriptMay 13, 2021$398 (-11.56%)Earnings
- Q4 2020 OpGen Inc Earnings Call TranscriptMar 25, 2021$540 (-0.74%)Earnings
- Q3 2020 OpGen Inc Earnings Call TranscriptNov 11, 2020$458 (+7.01%)Earnings
- Q2 2020 OpGen Inc Earnings Call TranscriptAug 12, 2020$522 (+1.95%)Earnings
- Q1 2020 OpGen Inc Earnings Call TranscriptMay 07, 2020$448 (-0.44%)Earnings
- Q4 2019 OpGen Inc Earnings Call TranscriptMar 24, 2020$598 (-4.47%)Earnings
- Q3 2019 OpGen Inc Earnings Call TranscriptNov 06, 2019$264 (+3.94%)Earnings
- OpGen Inc and Curetis NV Enter Into Definitive Agreement to Combine Businesses - M&A Call TranscriptSep 04, 2019
- Q2 2019 OpGen Inc Earnings Call TranscriptAug 07, 2019$1300 (+4.57%)Earnings
- Q1 2019 OpGen Inc Earnings Call TranscriptMay 14, 2019$1720 (-11.52%)Earnings
- Q4 2018 OpGen Inc Earnings Call TranscriptFeb 26, 2019$5760 (-4.00%)Earnings
Q4 2020 OpGen Inc Earnings Call Transcript
Welcome to the OpGen Fourth Quarter and Full Year 2020 Earnings Call and Business Update. (Operator Instructions) As a reminder, this conference call is being recorded today, March 25, 2021.
Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiaries Curetis and Ares Genetics. I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K for 2020 that will be filed with the SEC, which will identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Factors that may affect the company's results include, but are not limited to, our ability to successfully achieve the expected synergies from the company's completed business combination with Curetis and to implement the combined company's strategy, the impact of the continuing global COVID-19 pandemic on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)